MCID: DRM007
MIFTS: 51

Dermatitis Herpetiformis malady

Categories: Genetic diseases, Rare diseases, Skin diseases, Immune diseases

Aliases & Classifications for Dermatitis Herpetiformis

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 65UMLS, 27ICD10, 29ICD9CM, 42NCIt, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet, 61The Human Phenotype Ontology
See all MalaCards sources

Aliases & Descriptions for Dermatitis Herpetiformis:

Name: Dermatitis Herpetiformis 10 45 47 12 51 36 65
Duhring's Disease 10 45
Dermatitis Herpetiformis, Familial 65
Dermatosis Herpetiformis 10
 
Duhring Brocq Disease 45
Brocq-Duhring Disease 45
Durhing-Brocq Disease 51
Dh 45

Characteristics:

Orphanet epidemiological data:

51
dermatitis herpetiformis:
Inheritance: Not applicable; Prevalence: 1-5/10000 (Europe),1-9/1000000 (Italy),1-9/100000 (Ireland),1-5/10000 (Ireland); Age of onset: All ages


Classifications:

Orphanet: 51 
Rare skin diseases


External Ids:

Disease Ontology10 DOID:8505
ICD1027 L13.0
ICD9CM29 694.0
MeSH36 D003874
NCIt42 C26742
Orphanet51 1656
ICD10 via Orphanet28 L13.0
MESH via Orphanet37 D003874
UMLS via Orphanet66 C0011608
UMLS65 C0011608, C1832586

Summaries for Dermatitis Herpetiformis

About this section
NIH Rare Diseases:45 Dermatitis herpetiformis is a rare, chronic, skin disorder characterized by groups of severely itchy blisters and raised skin lesions. these are more common on the knees, elbows, buttocks and shoulder blades. the slow onset of symptoms usually begins during adulthood, but children can also be affected. other symptoms may include fluid-filled sores; red lesions that resemble hives; and itchiness, redness and burning. the exact cause of this disease is not known, but it is frequently associated with the inability to digest gluten. people with this disease are typically treated with the drug dapsone. last updated: 10/29/2014

MalaCards based summary: Dermatitis Herpetiformis, also known as duhring's disease, is related to typhus and purpura, and has symptoms including abnormal blistering of the skin, autoimmunity and recurrent fractures. An important gene associated with Dermatitis Herpetiformis is CD79A (CD79a Molecule), and among its related pathways are Primary immunodeficiency and A-beta Pathways: Uptake and Degradation. The drugs dapsone and sulfapyridine pwdr have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and breast, and related mouse phenotypes are renal/urinary system and homeostasis/metabolism.

Wikipedia:68 Dermatitis herpetiformis (DH), or Duhring\'s disease, is a chronic blistering skin condition,... more...

Related Diseases for Dermatitis Herpetiformis

About this section

Diseases in the Dermatitis Herpetiformis family:

Juvenile Dermatitis Herpetiformis

Diseases related to Dermatitis Herpetiformis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 507)
idRelated DiseaseScoreTop Affiliating Genes
1typhus30.8CD40LG, CD79A
2purpura30.8CD40LG, CD79A
3hemosiderosis30.7CD40LG, CD79A
4proliferative glomerulonephritis30.6CD40LG, CD79A
5weill-marchesani syndrome30.6CD40LG, CD79A
6villonodular synovitis30.6CD40LG, CD79A
7shigellosis30.5CD40LG, CD79A
8peripheral artery disease30.5CD40LG, CD79A
9focal hand dystonia30.3HLA-DQA1, HLA-DQB1
10rheumatoid arthritis29.8CD40LG, CD79A, HLA-DQA1, HLA-DQB1
11systemic lupus erythematosus29.6CD40LG, CD79A, HLA-DQA1, HLA-DQB1
12artery disease29.5HLA-DQA1, HLA-DQB1
13asthma29.3CD40LG, CD79A, HLA-DQA1, HLA-DQB1
14bullous pemphigoid29.2CD40LG, CD79A, FBN1, HLA-DQA1, HLA-DQB1, MMP12
15juvenile dermatitis herpetiformis12.6
16dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema11.8
17leukemia10.5
18pulmonary edema10.4CD40LG, CD79A
19congenital hypogammaglobulinemia10.4CD40LG, CD79A
20calabro syndrome10.4CD40LG, CD79A
21gamma heavy chain disease10.4CD40LG, CD79A
22exanthema subitum10.4CD40LG, CD79A
23prostatitis10.4
24osteomalacia10.4CD40LG, CD79A
25subcorneal pustular dermatosis10.4CD79A, HLA-DQB1
26epidermolysis bullosa simplex10.4CD40LG, CD79A
27cryopyrin-associated periodic syndrome10.4CD40LG, CD79A
28acute salpingitis10.4CD40LG, CD79A
29beriberi10.4CD40LG, CD79A
30cystitis10.4CD40LG, CD79A
31choroid plexus meningioma10.4CD40LG, CD79A
32immunotactoid glomerulopathy10.4CD40LG, CD79A
33ocular muscular dystrophy10.4CD79A, HLA-DQB1
34subacute delirium10.4CD40LG, CD79A
35alpha chain disease10.4CD40LG, CD79A
36dysgammaglobulinemia10.4CD40LG, CD79A
37generalized atherosclerosis10.4CD40LG, CD79A
38central sleep apnea10.4CD40LG, CD79A
39intellectual disability-obesity-prognathism-eye and skin anomalies syndrome10.4HLA-DQB1, MYO9B
40sialadenitis10.4CD40LG, CD79A
41ureteral lymphoma10.4CD40LG, CD79A
42mixed lacrimal gland cancer10.4CD40LG, CD79A
43somatoform disorder10.4CD40LG, CD79A
44aids phobia10.4CD40LG, CD79A
45ocular hypotension10.4CD40LG, CD79A
46differentiating neuroblastoma10.4CD40LG, CD79A
47tenosynovitis10.4CD40LG, CD79A
48brucella melitensis brucellosis10.4CD40LG, CD79A
49fallopian tube carcinoma10.4CD40LG, CD79A
50maxillary sinusitis10.4CD40LG, CD79A

Graphical network of the top 20 diseases related to Dermatitis Herpetiformis:



Diseases related to dermatitis herpetiformis

Symptoms for Dermatitis Herpetiformis

About this section

Symptoms:

 51 (show all 15)
  • urticaria
  • erythema/erythematous lesions/erythroderma/polymorphous erythema
  • macules
  • follicular/erythematous/edematous papules/milium
  • vesicles/bullous/exsudative lesions/bullous/cutaneous/mucosal detachment
  • negative nikolski's sign
  • pruritus/itching
  • malabsorption/chronic diarrhea/steatorrhea
  • mutiple fractures/bone fragility
  • autoimmunity/autoimmune reaction/autoantibodies
  • microcytic anemia
  • eczema
  • lichen
  • cutaneous edema
  • bone pain

HPO human phenotypes related to Dermatitis Herpetiformis:

(show all 13)
id Description Frequency HPO Source Accession
1 abnormal blistering of the skin hallmark (90%) HP:0008066
2 autoimmunity hallmark (90%) HP:0002960
3 recurrent fractures hallmark (90%) HP:0002757
4 malabsorption hallmark (90%) HP:0002024
5 microcytic anemia hallmark (90%) HP:0001935
6 hypermelanotic macule hallmark (90%) HP:0001034
7 urticaria hallmark (90%) HP:0001025
8 pruritus hallmark (90%) HP:0000989
9 eczema typical (50%) HP:0000964
10 lichenification occasional (7.5%) HP:0100725
11 bone pain occasional (7.5%) HP:0002653
12 edema occasional (7.5%) HP:0000969
13 pruritus HP:0000989

Drugs & Therapeutics for Dermatitis Herpetiformis

About this section

Drugs for Dermatitis Herpetiformis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1AntibodiesPhase 1, Phase 24477
2ImmunoglobulinsPhase 1, Phase 24477
3
Dapsoneapproved, investigational6280-08-02955
Synonyms:
(4-sulfanilylphenyl)amine
1,1'-Sulfonylbis(4-aminobenzene)
1,1'-Sulfonylbis[4-aminobenzene]
1,1'-Sulphonylbis(4-aminobenzene)
1358F
32960_FLUKA
4,4' Diaminophenyl Sulfone
4,4'-Dapsone
4,4'-Diaminodiphenyl sulfone
4,4'-Diaminodiphenyl sulphone
4,4'-Diaminodiphenyl suphone
4,4'-Diaminodiphenylsulfone
4,4'-Sulfonylbisaniline
4,4'-Sulfonylbisbenzamine
4,4'-Sulfonylbisbenzenamine
4,4'-Sulfonylbisbenzeneamine
4,4'-Sulfonyldianilin
4,4'-Sulfonyldianiline
4,4'-Sulfonyldianiline (Dapsone)
4,4'-Sulphonylbisbenzamine
4,4'-Sulphonylbisbenzenamine
4,4'-Sulphonyldianiline
4,4'-diaminophenyl sulfone
4,4'-sulfonyldianiline
4,4-Diaminodifenylsulfon
4,4-Diaminodifenylsulfon [Czech]
4,4-Sulfonyldianiline
4-(4-Aminophenylsulfonyl)aniline
4-(4-Aminophenylsulfonyl)benzenamine
4-(4-amino-Benzenesulfonyl)-phenylamine
4-(4-aminophenyl)sulfonylaniline
4-Aminop henyl sulfone
4-Aminophenyl sulfone
4-Aminophenylsulfone
4-[(4-aminobenzene)sulfonyl]aniline
4-[(4-aminophenyl)sulfonyl]aniline
46158_FLUKA
46158_RIEDEL
80-08-0
A74807_ALDRICH
AB00051962
AB1004833
AC-10922
AC1L1EUH
AC1Q51WM
AC1Q51WN
AI3-08087
AKOS000119322
ALBB-005917
AZT + Dapsone cominbation
Acedapsone
Aczone
Aczone (TN)
Ambap80-08-0
Araldite HT
Araldite HT 976
Araldite Ht
Atrisone
Avlosulfon
Avlosulfone
Avlosulphone
Avsulfor
BIDD:GT0770
BPBio1_000143
BRD-K62363391-001-05-8
BRN 0788055
BSPBio_000129
BSPBio_002129
Bis(4-aminophenyl) sulfone
Bis(4-aminophenyl)sulfone
Bis(4-aminophenyl)sulphone
Bis(P-aminophenyl) sulfone
Bis(p-aminophenyl) sulfone
Bis(p-aminophenyl)sulphone
C07666
CAS-80-08-0
CBDivE_013582
CCRIS 192
CHEBI:4325
CHEMBL1043
CID2955
CPD000059064
Croysulfone
Croysulphone
D SS
D003622
D00592
D0089
DADPS
DAPSONE
DB00250
DDS
DDS (pharmaceutical)
DDS, diaphenylsulfone
DDS, pharmaceutical
DIAPHENYLSULFONE
DSS
DSS (VAN)
Dapsoderm-X
Dapson
Dapson-Fatol
Dapsona
Dapsona [INN-Spanish]
Dapsone
Dapsone (USP)
Dapsone [USAN:BAN]
Dapsonum
Dapsonum [INN-Latin]
Dds, Diaphenylsulfone
Dds, Pharmaceutical
Di(4-aminophenyl) sulfone
Di(4-aminophenyl)sulfone
Di(4-aminophenyl)sulphone
Di(p-aminophenyl) sulfone
Di(p-aminophenyl)sulphone
Diamino-4,4'-diphenyl sulfone
Diamino-4,4'-diphenyl sulphone
Diamino-diphenyl sulphone
Diaminodifenilsulfona
Diaminodifenilsulfona [Spanish]
Diaminodiphenyl Sulfone
Diaminodiphenyl sulfone
Diaminodiphenylsulfone
Diaphenylsulfon
 
Diaphenylsulfone
Diaphenylsulfone (JAN)
Diaphenylsulphon
Diaphenylsulphone
Dimitone
Diphenasone
Diphone
Disulone
DivK1c_000573
Dubronax
Dubronaz
Dumitone
EINECS 201-248-4
Eporal
F 1358
Fatol Brand of Dapsone
HMS1568G11
HMS1920C14
HMS2091K04
HMS501M15
HSDB 5073
HT 976
HY 976
Hardener HT 976
I01-3640
ICI
IDI1_000573
IN-201
KBio1_000573
KBio2_001368
KBio2_003936
KBio2_006504
KBio3_001349
KBioGR_000900
KBioSS_001368
LS-1790
MLS000069409
MLS001055349
MLS001076146
Metabolite C
Mex-America Brand of Dapsone
MolPort-001-780-172
N, N'-Diphenyl Sulfondiamide
N, N'-Diphenyl sulfondiamide
N,N'-Diphenyl sulfondiamide
NCGC00016322-01
NCGC00016322-02
NCGC00023946-03
NCGC00023946-04
NCGC00023946-05
NCGC00023946-06
NCI-C01718
NINDS_000573
NSC 6091
NSC 6091D
NSC-6091
NSC6091
Normet
Novophone
Oprea1_143052
Orsade Brand of Dapsone
P, P'-Sulfonyldianiline
P,P'-Diaminodiphenyl Sulfone
P,P'-diaminodiphenyl sulfone
P,P-Diaminodiphenyl Sulphone
P,P-Sulfonylbisbenzamine
P,P-Sulfonylbisbenzenamine
P,P-Sulphonylbisbenzamine
P,P-Sulphonylbisbenzenamine
P,P-Sulphonyldianiline
P-Aminophenyl Sulfone
P-Aminophenyl sulfone
Prestwick0_000035
Prestwick1_000035
Prestwick2_000035
Prestwick3_000035
Prestwick_152
Protogen
Recolip
SAM002554879
SMR000059064
SPBio_001025
SPBio_002050
SPECTRUM1500222
STK387118
Spectrum2_001133
Spectrum3_000375
Spectrum4_000310
Spectrum5_000825
Spectrum_000888
Sulfadione
Sulfanona-Mae
Sulfanona-mae
Sulfon-Mere
Sulfon-mere
Sulfona
Sulfona-MAE
Sulfona-Mae
Sulfone Ucb
Sulfone ucb
Sulfone, 4,4'-Diaminophenyl
Sulfonyldianiline
Sulphadione
Sulphon-Mere
Sulphon-mere
Sulphonyldianiline
Sumicure S
TL8005401
Tarimyl
UNII-8W5C518302
Udolac
W R 448
WLN: ZR DSWR DZ
WR 448
ZINC00006310
dapsone
p, p'-Sulfonyldianiline
p,p'-Diaminodiphenyl sulfone
p,p'-sulfonyldianiline
p,p-Diaminodiphenyl sulphone
p,p-Sulfonylbisbenzamine
p,p-Sulfonylbisbenzenamine
p,p-Sulphonylbisbenzamine
p,p-Sulphonylbisbenzenamine
p,p-Sulphonyldianiline
p-Aminophenyl sulfone
4
Folic Acidapproved, nutraceutical292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
5Vitamin B Complex2847
6Folic Acid Antagonists1643
7Antiprotozoal Agents1730
8Anti-Bacterial Agents9140
9Antiparasitic Agents1854
10Anti-Infective Agents17220
11Antimalarials1058
12Vitamin B9Nutraceutical2924
13Folinic AcidNutraceutical2604
14FolateNutraceutical2924

Interventional clinical trials:

idNameStatusNCT IDPhase
1Study of Enzyme Supplements to Treat Celiac DiseaseActive, not recruitingNCT00962182Phase 1, Phase 2
2Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesRecruitingNCT01952275
3Use of Dapsone Gel, 5% for Treating Dermatitis HerpetiformisNot yet recruitingNCT01115244

Search NIH Clinical Center for Dermatitis Herpetiformis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: dermatitis herpetiformis

Genetic Tests for Dermatitis Herpetiformis

About this section

Anatomical Context for Dermatitis Herpetiformis

About this section

MalaCards organs/tissues related to Dermatitis Herpetiformis:

33
Skin, Bone, Breast, Endothelial, Liver, Heart, Lung

Animal Models for Dermatitis Herpetiformis or affiliated genes

About this section

MGI Mouse Phenotypes related to Dermatitis Herpetiformis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.5CD40LG, CD79A, FBN1, HLA-DQB1, TGM2
2MP:00053766.6CD40LG, CD79A, FBN1, HLA-DQB1, MMP12, MMP7
3MP:00053976.2CD40LG, CD79A, FBN1, HLA-DQA1, HLA-DQB1, MMP12
4MP:00053875.9CD40LG, CD79A, FBN1, HLA-DQA1, HLA-DQB1, MMP12

Publications for Dermatitis Herpetiformis

About this section

Articles related to Dermatitis Herpetiformis:

(show top 50)    (show all 570)
idTitleAuthorsYear
1
Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). (26009577)
2015
2
Bilateral double level tibial lengthening in dwarfism. (26566326)
2015
3
Identification of a Novel Four and a Half LIM Domain 1 Mutation in a Chinese Male Presented with Hypertrophic Cardiomyopathy and Mild Skeletal Muscle Hypertrophy. (26265627)
2015
4
Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. (26241911)
2015
5
Factors promoting sustainable work in women with fibromyalgia. (23336119)
2013
6
CXCR3 Modulates Obesity-Induced Visceral Adipose Inflammation and Systemic Insulin Resistance. (24124129)
2013
7
Giardiasis in a patient undergoing chemotherapy for retinoblastoma and acute myelogenous leukemia. (23910805)
2013
8
Hand-SchA1ller-Christian disease and Erdheim-Chester disease: coexistence and discrepancy. (23299772)
2013
9
Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. (23390174)
2013
10
Diagnosis of cystinosis from a bone marrow aspirate. (22911541)
2013
11
Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitment. (22529382)
2012
12
Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma. (22820936)
2012
13
Myeloma crystal tubulopathy and Fanconi syndrome: a rare histological finding. (22612270)
2012
14
Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function--a crossover trial (AGENT). (21906391)
2011
15
Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia. (22187799)
2011
16
Feminizing adrenocortical carcinoma with selective suppression of follicle-stimulating hormone secretion and disorganized steroidogenesis: a case report and literature review. (21720063)
2011
17
Fetal akinesia deformation sequence with delayed skeletal muscle maturation and polymicrogyria: evidence for a hypoxic/ischemic pathogenesis. (19968489)
2010
18
Magnetic separation of human podocalyxin-like protein 1 (hPCLP1)-positive cells from peripheral blood and umbilical cord blood using anti-hPCLP1 monoclonal antibody and protein A expressed on bacterial magnetic particles. (19293534)
2009
19
Serum proinflammatory cytokine - interleukin-8 as possible infection site marker in preterm deliveries. (19591568)
2009
20
p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma. (19846821)
2009
21
Novel transglutaminase-1 mutations and genotype-phenotype investigations of 104 patients with autosomal recessive congenital ichthyosis in the USA. (18948357)
2009
22
Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. (17924978)
2008
23
Activated protein C via PAR1 receptor regulates survival of neurons under conditions of glutamate excitotoxicity. (18620539)
2008
24
Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry. (18006945)
2007
25
Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. (17875969)
2007
26
Initial experience of subfascial endoscopic perforator vein surgery in patients with severe chronic venous insufficiency. (17966938)
2007
27
Monocyte chemotactic protein-1 expression in coronary atherosclerosis plaque of sudden coronary death patients]. (17081360)
2006
28
Activation of sterol regulatory element-binding proteins (SREBPs) is critical in IL-8-induced angiogenesis. (16849610)
2006
29
P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. (15686781)
2005
30
Viral and host causes of fatty liver in chronic hepatitis B. (15918189)
2005
31
High-throughput screening for kinase inhibitors. (15742384)
2005
32
Sphingosine 1-phosphate and platelet-derived growth factor (PDGF) act via PDGF beta receptor-sphingosine 1-phosphate receptor complexes in airway smooth muscle cells. (12480944)
2003
33
Catamenial pneumothorax: can all cases be explained by the pore hypothesis? (12907574)
2003
34
Dyslipidemia and the metabolic syndrome]. (15040160)
2003
35
Current and future status of adjuvant therapy for breast cancer. (12548590)
2003
36
Effect of intravenous bisphosphonates on release of basic fibroblast growth factor in serum of patients with cancer-associated hypercalcemia. (12005179)
2002
37
Role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine. Current hypotheses]. (11072640)
2000
38
Transcript identification on the CLN5 region on chromosome 13q22. (10480355)
1999
39
Differences in glomerular leukocyte infiltration between IgA nephropathy and membranoproliferative glomerulonephritis. (9550635)
1998
40
Role of the C terminus of the interleukin 8 receptor in signal transduction and internalization. (8702597)
1996
41
Pingyangmycin as a 99mTc carrier in tumor localization. (7550032)
1995
42
The genetics of infantile hypertrophic pyloric stenosis. A reanalysis. (8237916)
1993
43
Over-estimation of the number of complement receptor type 1 (CR1) on erythrocytes. (1535450)
1992
44
Molecular heterogeneity of the gamma-aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporters from rat brain. (1400419)
1992
45
Retroviral expression of recombinant p47phox protein by Epstein-Barr virus-transformed B lymphocytes from a patient with autosomal chronic granulomatous disease. (1313715)
1992
46
Lymphangiomatosis of the arm with massive osteolysis. A case report. (3440657)
1987
47
Nemaline myopathy. (506794)
1979
48
Enzymic differentiation between different types of Tay-Sachs disease of similar clinical appearance. (4336274)
1972
49
Chronic hypervitaminosis A; report of a probable case in a man. (13265422)
1955
50

Variations for Dermatitis Herpetiformis

About this section

Expression for genes affiliated with Dermatitis Herpetiformis

About this section
Search GEO for disease gene expression data for Dermatitis Herpetiformis.

Pathways for genes affiliated with Dermatitis Herpetiformis

About this section

Pathways related to Dermatitis Herpetiformis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.8CD40LG, CD79A
29.6CD40LG, MMP12
3
Show member pathways
9.1CD40LG, HLA-DQA1, HLA-DQB1
49.1CD40LG, HLA-DQA1, HLA-DQB1

GO Terms for genes affiliated with Dermatitis Herpetiformis

About this section

Cellular components related to Dermatitis Herpetiformis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:00426139.9HLA-DQA1, HLA-DQB1
2integral component of lumenal side of endoplasmic reticulum membraneGO:00715569.8HLA-DQA1, HLA-DQB1
3trans-Golgi network membraneGO:00325889.5HLA-DQA1, HLA-DQB1
4ER to Golgi transport vesicle membraneGO:00125079.2HLA-DQA1, HLA-DQB1

Biological processes related to Dermatitis Herpetiformis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1antigen processing and presentationGO:00198829.7HLA-DQA1, HLA-DQB1
2extracellular matrix disassemblyGO:00226178.7FBN1, MMP12, MMP7

Molecular functions related to Dermatitis Herpetiformis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein-glutamine gamma-glutamyltransferase activityGO:00038109.9TGM3, TGM6
2zinc ion bindingGO:00082709.0MMP12, MMP7, MYO9B

Sources for Dermatitis Herpetiformis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet